Select Publications

Bukowski RM et al. Safety and efficacy of sorafenib in elderly patients (pts) ≥65 years: A subset analysis from the Advanced Renal Cell Carcinoma Sorafenib (ARCCS) Expanded Access Program in North America. Proc ASCO 2008;Abstract 5045.

Bukowski RM et al. Randomized phase II study of erlotinib combined with bevaci­zumab compared with bevacizumab alone in metastatic renal cell cancer. J Clin Oncol 2007;25(29):4536-41. Abstract

Cooney MM et al. Sunitinib and bevacizumab in advanced solid tumors: A phase I trial. Proc ASCO 2008;Abstract 3530.

Escudier BJ et al. Update on AVOREN trial in metastatic renal cell carcinoma (mRCC): Efficacy and safety in subgroups of patients (pts) and pharmacokinetic (PK) analysis. Proc ASCO 2008;Abstract 5025.

Escudier B et al; AVOREN trial investigators. Bevacizumab plus interferon alfa-2a for treat­ment of metastatic renal cell carcinoma: A randomised, double-blind phase III trial. Lancet 2007;370(9605):2103-11. Abstract

Feldman DR et al. Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma. Proc ASCO 2008;Abstract 5100.

Hainsworth JD et al. Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib. J Clin Oncol 2005;23(31):7889-96. Abstract

Melichar B et al. First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma. Ann Oncol 2008;[Epub ahead of print]. Abstract

Rini BI et al. CALGB 90206: A phase III trial of bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in metastatic renal cell carcinoma. Proc ASCO Genitourinary Cancers Symposium 2008;Abstract 350.

Sosman JA et al. Updated results of phase I trial of sorafenib (S) and bevacizumab (B) in patients with metastatic renal cell cancer (mRCC). Proc ASCO 2008;Abstract 5011.

Yang JC et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003;349(5):427-34. Abstract

 

Home

Editor
Neil Love, MD

Interviews

Robert A Figlin, MD
- Select publications

Gary R Hudes, MD
- Select publications

Ronald M Bukowski, MD
- Select publications

CME Information

Faculty Disclosures

Editor's Office